Skip to content

Effectiveness of mindfulness meditation for low back pain: a randomized controlled trial

Effectiveness of mindfulness meditation for low back pain: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000373
Enrollment
56
Registered
2010-06-28
Start date
2009-10-22
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M54.9

Interventions

Group 1: Intervention group: Mindfulness easily learned meditation: an 8-week meditation program with recommendation to continue this at home daily. Group 2: Control group: an 8-week back written advi

Sponsors

Abteilung für Naturheilkunde, Charité Berlin, im Immanuel Krankenhaus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients an age between 18 to 65 years 2. Pre-existing diagnosis of a chronic low back pain, established by a specialist (orthopaedics, neurology, pain therapy) since at least 3 months 3. Average low back pain intensity with a minimum of 40 mm on VAS from 0 to 100 mm

Exclusion criteria

Exclusion criteria: 1. Invasive treatments in the spine within the last 6 weeks or planned within the next 8 weeks 2. Acute prolapse of vertebral disk (diagnosis within the last 3 months) 3. Congenital anomalies in the lumbar spine area 4. Rheumatoid arthritis 5. Acute mental illness 6. Serious pathology, somatic diseases 7. Pregnancy 8. Regularly exercised mindfulness meditation 9. Concurrent participation in another clinical study

Design outcomes

Secondary

MeasureTime frame
Roland-Morris Disability Index; 100 mm VAS for the average interference by low back pains during the last week; Questionnaires for the assessment of the pain-conditioned barrier in different areas of life by low back pain; Evaluation of the general state of health with SF 36; Overall assessment of the effectiveness and compatibility (Likert scale); Mood, fear, depression (Zerssen, POMS,HADS); Affective pain assessment („SES“); Intensity / frequency of analgesic basic medication and demand medication (diary); Compatibility based on query of the adverse events.

Primary

MeasureTime frame
100 mm VAS for the average low back pain intensity during the last week (Baseline versus End)

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026